Retraction Note: BMC Complement Altern Med 15, 315 (2015)
https://doi.org/10.1186/s12906-015-0839-5
The Editor has retracted this article because of significant concerns regarding a number of Figures presented in this work, which question the integrity of the data. Specifically:
-
Image overlap has been found in Figure 3A between images with different data labels: Normal HUVECs and LPS+valsartan; as well as LPS+Calycosin and LPS+valsartan
-
It appears that Figure 7c B-actin blot has unexpected similarity to Figure 7A actin blot, although this image has been flipped and edited.
In addition, there are inconsistencies between Figure 7 and the underlying data. The Editor therefore no longer has confidence in the integrity of the data in this article.
Author Yue-Hua Jiang agrees to this retraction. Corresponding author Wei Li has stated on behalf of all co-authors that they agree to this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Jiang, YH., Sun, W., Li, W. et al. Retraction Note: Calycosin-7-O-β-D-glucoside promotes oxidative stress-induced cytoskeleton reorganization through integrin-linked kinase signaling pathway in vascular endothelial cells. BMC Complement Med Ther 22, 329 (2022). https://doi.org/10.1186/s12906-022-03817-5
Published:
DOI: https://doi.org/10.1186/s12906-022-03817-5